Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

NERV holding history

Minerva Neurosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NERV overviewAll 13F holders of NERVFull Q2 2026 holdings

Shares (Q2 2026)
42,208
Value
$234.3K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of NERV by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,208$234.3K<0.1%−25,362−37.5%ReducedHolders
Q1 202667,570$407.1K<0.1%+65,763+3,639.3%AddedHolders
Q4 20251,807$7.26K<0.1%+1,797+17,970.0%AddedHolders
Q3 202510$21<0.1%−865−98.9%ReducedHolders
Q2 2025875$1.50K<0.1%−746−46.0%ReducedHolders
Q1 20251,621$2.76K<0.1%+1,609+13,408.3%AddedHolders
Q4 202412$27<0.1%−10,540−99.9%ReducedHolders
Q3 202410,552$28.2K<0.1%+10,542+105,420.0%AddedHolders
Q2 202410$32<0.1%00.0%UnchangedHolders
Q1 202410$26<0.1%−55−84.6%ReducedHolders
Q4 202365$400<0.1%+12+22.6%AddedHolders
Q3 202353$366<0.1%−381−87.8%ReducedHolders
Q2 2023434$3.97K<0.1%+434NewHolders
Q4 20220$00.0%−5,732−100.0%Sold outHolders
Q3 20225,732$53.0K<0.1%+5,167+914.5%AddedHolders
Q2 2022565$2.00K<0.1%+563+26,488.2%AddedConverted for a 1-for-8 splitHolders
Q1 202217$00.0%00.0%UnchangedHolders
Q4 202117$00.0%00.0%UnchangedHolders
Q3 202117$00.0%−9,311−99.8%ReducedHolders
Q2 20219,328$22.0K<0.1%−16,685−64.1%ReducedHolders
Q1 202126,013$76.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.